CD274 and neoplasm: In this way, PDL1.CCR is expected to block PDL1/PD1 interaction of CAR‐T cells and macrophages with PDL1+ tumor cells, mimicking an immune checkpoint effect and reducing CAR‐T cell exhaustion [188].